Alenka Spindler-vesel

This study is testing whether an intravenous (IV) medication called eptinezumab can help reduce severe facial pain that hasn't responded to other treatments. It will involve 10 people with conditions like trigeminal neuralgia or burning mouth syndrome. Researchers will give the d…